Monotherapy of Parkinson's disease with budipine - A randomised double-blind comparision to amantadine;Monotherapie der Parkinsonschen erkrankung mit budipin - Ein randomisierter doppelblindvergleich mit amantadin

Fortschritte der Neurologie Psychiatrie

Volumn 69, Issue 2, 2001, Pages 86-89

  Malsch, U ^a   Bliesath, H ^a   Bother K ^a   Luhmann R ^a   Ramm, H ^a  

^a Inst fur Medizinforsch Allensbach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BUDIPINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; ESSENTIAL TREMOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMANTADINE; ANTIPARKINSON AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PIPERIDINES;

EID: 0035127257     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-11171     Document Type: Article

References (17)

1. Beeinflussung des Parkinson-Tremors durch Budipin
2. Adjuvant treatment of Parkinson's disease with budipine. A double blind trial versus placebo
3. The protective effect of 1-tertbutyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl 1,2,3,6-tetrahydropiperidine
4. Budipine provides additional benefit in stable, non fluctuating parkinsonian patients on dopaminergic drugs
5. Zusammenfassende Darstellung der Pharmakologie von Budipin, einem neuen 4,4-Diphenylpiperedinderivat für die Parkinson-Therapie
6. Multiple mechanisms of action: The pharmacological profile of budipine
7. Pharmacokinetics and metabolism of budipine in animals and humans
8. Treatment of Parkinson's disease in early and late phases
9. Intense oxidative DNA damage promoted by L-Dopa and its metabolites: Implications for neurodegenerative disease
10. L-Dopa increases nigral production of hydroxyl radicals in vivo: Potential L-Dopa toxicity
11. Introduction of apoptosis in catecholaminergic PC12 cells by L-Dopa: Implications for the treatment of Parkinson's disease
12. Critical analysis of the disability in Parkinson's disease
13. The depression status inventory: An adjunct of the selfrating depression scale
14. A nonparametric comparison of two small samples with many ties
15. Beeinflussung des Parkinson-Tremors durch Budipin
16. Clinical Experience with Budipine in Parkinsonian Therapy
17. Clinical efficacy of budipine in Parkinsons's disease